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Hepatic stellate cells (HSC) play an important role in the development of liver ﬁbrosis. Here, we report that HSC express the stem/
progenitor cell marker CD133 and exhibit properties of progenitor cells. CD133+ HSC of rats were selected by speciﬁc antibodies and
magnetic cell sorting. Selected cells displayed typical markers of HSC, endothelial progenitor cells (EPC), and monocytes. In cell culture,
CD133+ HSC transformed into a-smooth muscle actin positive myoﬁbroblast-like cells, whereas application of cytokines known to facil-
itate EPC diﬀerentiation into endothelial cells led to the formation of branched tube-like structures and induced expression of the endo-
thelial cell markers endothelial nitric oxide synthase and vascular-endothelial cadherin. Moreover, cytokines that guide stem cells to
develop hepatocytes led to the appearance of rotund cells and expression of the hepatocyte markers a-fetoprotein and albumin. It is con-
cluded that CD133+ HSC are a not yet recognized progenitor cell compartment with characteristics of early EPC. Their potential to
diﬀerentiate into endothelial or hepatocyte lineages suggests important functions of CD133+ HSC during liver regeneration.
 2006 Elsevier Inc.
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Open access under  CC BY-NC-ND license.Liver ﬁbrosis is characterized by excess deposition of
collagens, resulting in an impairment of liver function
and hemodynamics and ﬁnally organ failure. A major play-
er in the process of ﬁbrogenesis is the hepatic stellate cell
(HSC). In the quiescent state, HSC are vitamin A (mainly
retinyl palmitate) storing cells [1] located between sinusoi-
dal endothelial cells and hepatocytes in the space of Disse´.
HSC are further characterized by their stellate-shaped mor-
phology, perinuclear lipid droplets, and expression of the
proteins desmin [2] and glial ﬁbrillary acidic protein
(GFAP) [3]. Following liver injury HSC become activated,
loose their vitamin A stores and transform into a myoﬁbro-
blast-like phenotype. These myoﬁbroblasts are contractile
and synthesize a-smooth muscle actin (a-SMA) and
extra-cellular matrix proteins such as collagen (type 1).0006-291X  2006 Elsevier Inc.
doi:10.1016/j.bbrc.2006.11.029
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Open access under CC BY-NC-ND license.Despite intensive research on the biology and patho-
physiological role of HSC, their embryonic origin is still
a matter of debate, because stellate cells synthesize pro-
tein markers of all three embryonic germ layers. Stem
cells of the bone marrow can generate cells of all germ
layers and HSC were suggested to derive from the bone
marrow [4,5]. Moreover, the stem cell markers nestin,
CD105, p75 neurotrophin receptor (p75NTR), and c-kit
ligand were detected in HSC [6–9]. These ﬁndings
prompted us to test the hypothesis of whether HSC are
undiﬀerentiated stem or progenitor cells. In the course
of our studies it turned out that HSC express CD133
(AC133/prominin 1). The cell surface protein CD133 is
characteristic for stem/progenitor cells derived from the
hematopoietic system and was used here to allow separa-
tion and description of a deﬁned HSC population. The
selected CD133+ HSC expressed a variety of stem/pro-
genitor cell markers and displayed the capacity to develop
into myoﬁbroblast-like, endothelial-like, and hepatocyte-
like cells in vitro.
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Cell isolation and selection. Stellate cells were obtained from the liver of
male Wistar rats (500–600 g body weight). HSCs were isolated according
to a standard protocol using enzymatic digestion of liver tissue and enri-
ched by a single density gradient (8% Nycodenz, Axis-Shield, Oslo, Nor-
way) essentially as described earlier [1]. Obtained HSC were suspended in
10 ml Hanks’ balanced salt solution containing 0.25% bovine serum
albumin and 50 lg/ml DNase I. Unspeciﬁc binding of primary antibody
was blocked with immunoglobulins against CD16 and CD32 (1 lg per
million cells). Selection of cells was achieved using 3 lg/ml of a biotinyl-
ated antibody against CD133 and the EasySep cell separation kit (Stem-
Cell Technologies, Vancouver, Canada) according to the manufacturer’s
recommendations. All antibodies used for cell selection are listed in
Supplemental Table S1.
Cultivation and treatment of cells. Selected cells were cultured in Dul-
becco’s modiﬁed Eagle’s medium (DMEM) containing 20 ng/ml platelet-
derived growth factor (PDGF-BB) and 10% fetal calf serum (FCS) on
plastic in order to facilitate transformation of cells into myoﬁbroblast-like
cells. Iscove’s modiﬁed Dulbecco’s medium (IMDM) supplemented with
50 ng/ml vascular endothelial growth factor (VEGF164; R&D Systems,
Minneapolis, MN, USA), 20 ng/ml basic ﬁbroblast growth factor (bFGF),
10 ng/ml erythropoietin (EPO), 10 ng/ml interleukin-6 (IL-6; Sigma,
Taufkirchen, Germany), and 15% FCS (FCS for endothelial cell diﬀer-
entiation; StemCell Technologies) was used to promote diﬀerentiation of
selected cells into endothelial-like cells. For induction of cell diﬀerentiation
into hepatocyte-like cells freshly isolated CD133+ HSC were exposed for
an initial period of 3 days to IMDM containing 50 ng/ml FGF4 (R&D
Systems), 50 ng/ml bFGF, 40 ng/ml hepatocyte growth factor (HGF;
Sigma), 10 ng/ml IL-6, and 10% FCS. The medium was thereafter changed
to IMDM containing 50 ng/ml FGF4 and 5% FCS. All media were
exchanged daily. For cell diﬀerentiation into endothelial or hepatocyte
lineages the CD133+ HSC were cultured on a thick layer of self made
collagen (type 1) from rat tail. To investigate the cellular uptake of ﬂuo-
rescent acetylated low density lipoprotein (DIL-AC-LDL; Biogenesis,
Poole, UK) the cultured cells were treated for 4 h with 2.5 lg/ml DIL-AC-
LDL at 37 C.
Analysis of cells. Freshly isolated and cultured CD133+ HSC were
analysed by immunoﬂuorescence staining and Western blot according to
standard protocols. The primary and secondary antibodies used are listed
in Supplemental Table S1. Actin ﬁlaments of HSC were stained by phal-
loidin-TRITC (Sigma) and the cell nuclei were marked with DAPI (4 0,6-
diamino-2-phenylindole) by covering of cells with ProLong Gold
(Molecular Probes, Invitrogen, Karlsruhe, Germany). Fluorescence
images were taken by a confocal laser scanning microscope. The retinol
and retinyl palmitate content of selected cells was measured by high-per-
formance liquid chromatography (HPLC) essentially as described else-
where [10]. The gene expression pattern of CD133+ HSC was investigated
by reverse transcriptase-polymerase chain reaction (RT-PCR). Five
nanograms of puriﬁed mRNA per 20 ll reaction volume was used for
synthesis of the ﬁrst strand cDNA. The PCR was performed according to
standard procedures. All PCR products obtained were sequenced to prove
speciﬁcity of primer sets (Supplemental Table S2). A full view on agarose
gels of PCR-products and comparisons of gene expressions is given in
Supplemental Figs. S1–S3.Results
HSC express CD133: selection and characterization of
CD133+ HSC
The stem/progenitor cell marker CD133 was detected in
HSC, which were isolated from rat liver and enriched by a
density gradient. Speciﬁc antibodies against CD133 were
used to select a deﬁned population of enriched HSC bymagnetic cell sorting. About 20–40% of the HSC was sep-
arated by this method. Separated cells displayed stellate-
like morphology with lipid droplets and synthesized
CD133 protein as well as the typical HSC marker proteins
desmin and GFAP as shown by immunoﬂuorescence, Wes-
tern blot, and RT-PCR (Fig. 1A–G). The lipid inclusions
of selected cells were analysed by HPLC and low values
of retinol, but high amounts of retinyl palmitate were mea-
sured (Fig. 1H). The purity of separated cells was tested by
RT-PCR. No typical marker proteins of other liver cell
types were found in CD133+ stellate cells. The cells were
negative for a-SMA, elastin, endothelial nitric oxide syn-
thase (eNOS), vaso-endothelial cadherin (ve-CAD), stabi-
lin 2, scavenger receptor F1 (SCARF1), C-type lectin 13,
a-fetoprotein (a-FP), and albumin (Supplemental Fig. S1).
Stem/progenitor cell markers in CD133+ HSC
Selected CD133+ HSC displayed marker proteins of
pluripotent stem cells like OCT4 and nanog as demon-
strated by immunoﬂuorescence. OCT4 was stained pre-
dominantly in the nucleus of all selected cells (Fig. 2A).
Nanog was also detected in each CD133+ HSC, but this
transcription factor displayed no or only weak nuclear
staining (Fig. 2B). The occurrence of both proteins was
veriﬁed by Western blot analysis (Fig. 3A and B). Other
proteins known to be synthesized by stem/progenitor
cells such as c-kit, paired-like homeodomain transcription
factor 2 isoform c (PITX2c), musashi 1 (MSI1), and
CXCR4 were also investigated by immunoﬂuorescence
in CD133+ HSC (Fig. 2C–F). PITX2c and MSI1 were
stained predominantly in the cell nuclei (Fig. 2D and
E). The presence of PITX2c and THY1 was conﬁrmed
by Western blot (Fig. 3C and D).
These and additional stem/progenitor cell markers were
also investigated by RT-PCR in freshly isolated CD133+
HSC. The mRNAs of OCT3/4, c-kit, c-kit ligand, PITX2c,
THY1, FMS-like tyrosine kinase 3 (FLT3), FLT3 ligand,
stem cell growth factor (SCGF), breast cancer resistance
protein 1 (BCRP1), Slain1, nucleostemin, nestin,
p75NTR, wingless type 9b (WNT9b), and MSI1 were
detected by this method, whereas nanog mRNA was not
found (Fig. 3E).
CD133+ HSC express markers of EPC and monocytes
We detected the mRNA of proteins characteristic for
EPC such as fetal like kinase 1 (FLK1), FLT1, angiopoie-
tin receptor 1 precursor (TIE2), runt-related transcription
factor 1 (RUNX1), CD105, bone morphogenetic protein-
binding endothelial regulator (BMPER), CD31, and
von Willebrand factor (vWF; Fig. 3F). In addition to
EPC markers, CD133+ HSC were found to synthesize
mRNA characteristic of cells derived from the hematopoi-
etic system. CXCR4 and the monocyte marker CD14 were
detected at the mRNA and protein level (Figs. 2F and 3G
and H).
Fig. 1. HSC express CD133 and display typical properties of stellate cells. CD133+ HSC were analysed after magnetic cell sorting (A–H). The cells were
cultured on glass coverslips for 24 h (A–D). Phase contrast microscopic image of CD133+ HSC (A). Immunoﬂuorescence staining (red) of CD133 (B),
desmin (C), and GFAP (D). Cell nuclei were marked by DAPI (blue, B–D). CD133+ HSC were lysed for RT-PCR and Western blot directly after
selection. mRNA (dark lanes) and protein samples (bright lanes) were analysed for CD133 (E), desmin (F), and GFAP (G). The retinol and retinyl
palmitate content of freshly selected CD133+ HSC were measured by HPLC (H). Retinyl palmitate values per mg protein of cell lysates of independent cell
separations are displayed within the box.
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Fig. 2. Stem/progenitor cell marker proteins in CD133+ HSC. Immunoﬂuorescence stainings of CD133+ HSC cultured for 24 h using antibodies against
OCT4 (A), nanog (B), c-kit (C, cell nuclei were stained by DAPI), PITX2c (D), MSI1 (E), and CXCR4 (F).
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When CD133+ HSC were cultured with medium con-
taining PDGF-BB on plastic for 7 days, they transformed
into myoﬁbroblast-like cells. This development was accom-
panied by a gradual loss of lipid stores, an increase of cell
size, and the onset of a-SMA synthesis (Fig. 4A–D). The
expression of CD133 disappeared and FLK1 mRNA levels
decreased under this culture condition. Marker proteins of
mature endothelial cells (eNOS, ve-CAD) or heptocytes (a-
fetoprotein/a-FP, albumin) were neither detected in freshly
isolated CD133+ HSC nor in myoﬁbroblast-like cells
(Fig. 4E).
Treatment of CD133+ HSC grown on collagen with
medium containing VEGF164, bFGF, EPO, and IL-6,
i.e. conditions known to promote diﬀerentiation of EPC
to endothelial cells, induced the formation of tube-like
structures within 7 days of culture. This process was initi-
ated by a reduction of lipid inclusions, followed by prolif-
eration and migration of cells and ﬁnally resulted in the
development of branched tubular structures (Fig. 4F–I).The tubular structures displayed discontinuous cavities
as shown by confocal laser scanning microscopy (Supple-
mental Fig. S4). These structures were not formed by
other cell types such as isolated sinusoidal endothelial
cells or ﬁbroblasts, when treated with the same medium
on collagen (Supplemental Fig. S5G and K). After tube
formation by CD133+ HSC we observed reduced, but still
detectable CD133 expression, indicating that CD133+
HSC maintained characteristics of undiﬀerentiated cells
during proliferation. The FLK1 mRNA synthesis declined
only slightly under these culture conditions. Furthermore,
this cytokine treatment induced the mRNA synthesis of
eNOS and ve-CAD (Fig. 4J). The continuous FLK1
expression as well as the synthesis of eNOS and
ve-CAD mRNA indicates that endothelial-like cells devel-
oped in this culture system. This view was supported by
the induction of the stabilin 2 and SCARF1 mRNA
(Supplemental Fig. S3Q1 and R1) and uptake of DIL-
AC-LDL by cells surrounding tubular structures (Supple-
mental Fig. S5D). DIL-AC-LDL was not incorporated by
freshly isolated CD133+ HSC or myoﬁbroblast-like cells
Fig. 3. Detection of marker proteins of stem/progenitor cells, EPC, and monocytes immediately after selection of CD133+ HSC. The stem/progenitor
cell markers OCT4 (A), nanog (B), PITX2c (C), and THY1 (D) were investigated by Western blot analysis. CD133+ HSC were also analysed by
RT-PCR for molecular markers of stem/progenitor cells (E), EPC (F), and monocytes (G). The monocyte marker CD14 was detected by Western
blot (H).
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blast marker a-SMA was observed after tube formation.
Also markers of hepatocytes such as a-fetoprotein and
albumin were not detectable (Fig. 4J).
CD133+ HSC cultured on collagen were treated with
FGF4, HGF, bFGF, and IL-6 to investigate whether these
cells can also diﬀerentiate into the hepatocyte lineage.
Under these conditions, selected cells lost their lipid stores,
started to proliferate, and between days 4 and 7 of cytokine
treatment rotund cells appeared in the culture system
(Fig. 4K–O). The cytokine cocktail induced the mRNA
synthesis of hepatocyte markers like a-fetoprotein, albu-
min, and multidrug resistance protein 2 (MRP2; Fig. 4P;
Supplemental Fig. S3). Rotund cells, approximately25–50 lm in diameter, were removed from the cell culture
to investigate their protein synthesis by immunoﬂuores-
cence staining. The cells synthesized the hepatocyte marker
a-fetoprotein (Fig. 4O), indicating that non-polarized
hepatocyte-like cells developed from CD133+ HSC. Under
these culture conditions, the expression of CD133 and
FLK1 decreased. The mRNA of molecular markers of
endothelial cells or myoﬁbroblasts was not induced. Inter-
estingly, an expression of CD34 was not detected in freshly
isolated CD133+ HSC as investigated by RT-PCR
(Fig. 4E, J, and P) and immunoﬂuorescence staining (not
shown), but increased under culture conditions favoring
the development of myoﬁbroblast-like, endothelial-like,
and hepatocyte-like cells (Fig. 4E, J, and P).
Fig. 4. Culture experiments with CD133+ HSC to reveal their diﬀerentiation capacity. Selected HSC were cultured with medium supplemented with
PDGF-BB to promote development of myoﬁbroblast-like cells in plastic culture dishes (A–E). Phase contrast microscopic images of CD133+ HSC after 1
(A), 3 (B), and 7 days (C) of culture. Immunoﬂuorescence staining of a-SMA after 7 days of culture (D). CD133+ HSC were lysed for RT-PCR analysis
directly without culturing (0d) and after 7 days (7d) of cultivation (E). The selected HSC were also cultured with medium containing VEGF164, bFGF,
EPO, and IL-6 on collagen to facilitate EPC diﬀerentiation (F–J). Phase contrast microscopic images of CD133+ HSC cultured for 1 (F), 3 (G), and 7 days
(H). Macroscopic view of tube-like structures after 7 days of culture (I). RT-PCR analysis of freshly selected and cultured HSC after treatment with
medium promoting EPC diﬀerentiation (J). CD133+ HSC were cultured on collagen and treated with medium containing FGF4, bFGF, HGF, and IL-6 to
facilitate cell diﬀerentiation into hepatocytes (K–P). Phase contrast microscopic images of CD133+ HSC were taken after 1 (K), 3 (L), and 7 days (M and
N). The hepatocyte marker a-fetoprotein (a-FP) was detected by immunoﬂuorescence staining in rotund cells (O). Changes in gene expression of CD133+
HSC after treatment with FGF4, bFGF, HGF, and IL-6 were analysed by RT-PCR in freshly isolated and cultured cells (P).
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CD133+ HSC possess characteristics of typical stellate cells
and EPC
The present study shows that stellate cells of the rat liver
express the hematopoietic stem/progenitor cell marker
CD133. CD133+ HSC exhibit typical properties of stellate
cells such as the characteristic cell morphology with perinu-
clear lipid droplets, high retinyl palmitate content, and syn-
thesis of the HSC marker proteins desmin and GFAP.
When CD133+ HSC were cultured on plastic they trans-
formed into myoﬁbroblast-like cells as described in many
studies using isolated HSC. However, stellate cells express-
ing CD133 displayed a variety of features also found in
progenitor cells such as EPC. Bone marrow-derived early
EPC are negative for molecular markers of more matureendothelial cells like ve-CAD and eNOS, but their expres-
sion appears during diﬀerentiation of EPC [11]. A similar
situation was observed in freshly isolated CD133+ HSC.
These cells expressed markers of EPC, and proteins of
mature endothelial cells (eNOS, ve-CAD, stabilin 2,
SCARF1) were induced after application of cytokines
which favor diﬀerentiation of EPC into endothelial cells.
In line with this, features of mature endothelial cells like
endocytosis of DIL-AC-LDL emerged during endothelial
diﬀerentiation of CD133+ HSC, indicating that functional
endothelial-like cells developed from CD133+ HSC. The
formation of tube-like structures observed in cultured
CD133+ HSC is another feature pointing towards EPC
[12]. The view that CD133+ HSC possess characteristics
of EPC was further strengthened by their CD14 expression.
This monocyte marker was reported to occur in EPC with
low abundance of CD34 [13]. Albeit CD34 was already
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established marker of hematopoietic cells and EPC was
not expressed by freshly isolated CD133+ HSC, but
increased in cultured cells. At present, the relevance of ele-
vated CD34 expression during cultivation of CD133+ HSC
is unknown.
Stem/progenitor cell markers in CD133+ HSC
Apart from EPC characteristics, CD133+ HSC
expressed many genes commonly used to identify stem/pro-
genitor cells. Some of them are new or less frequently used
markers such as WNT9b, Slain1, nucleostemin, and
PITX2c. WNT9b as well as MSI1 are expressed by stem
cells in the crypts of the small intestine [15,16]. Slain1
and nucleostemin are newly discovered stem cell markers
also found in pluripotent embryonic stem cells [17,18].
The PITX2c isoform appears in primitive hematopoietic
stem/progenitor cells and its expression declines during
their diﬀerentiation [19]. A similar behaviour was observed
here in primary cultures of total HSC (not shown).
CD133+ HSC also show protein synthesis of OCT4 and
nanog, markers formerly known to be expressed in embry-
onic stem cells. These markers were recently also described
in EPC [13]. The mRNA of nanog was not detected in
freshly isolated CD133+ HSC, but the occurrence of the
protein nanog was veriﬁed by Western blot analysis and
immunoﬂuorescent cell staining. In contrast to OCT4, the
homeobox transcription factor nanog was not clearly
observed in the nuclei of CD133+ HSC, suggesting a
reduced function of nanog at this stage.
CD133+ HSC and liver regeneration
Despite controversies regarding the quantitative contri-
bution, stem/progenitor cells participate in liver regenera-
tion and the question on the role of HSC in this process
arises. The appearance of so-called ductular structures dur-
ing renewal of liver tissue is thought to represent a stem cell
response. It is at present speculative whether the observed
formation of tube-like structures by CD133+ HSC in vitro
corresponds to the ductular structures in vivo, but trans-
planted EPC were reported to form tube-like structures
in the injured liver [12]. Moreover, hematopoietic progeni-
tor cells characterized by CD133, CD14, CD45, and
CXCR4 appear in the peripheral blood of healthy humans
after partial hepatectomy and these cells diﬀerentiate into
hepatocytes in vitro [20]. Also CD133+ HSC display the cell
surface proteins CD14 and CXCR4, raising the question of
whether CD133+ HSC can diﬀerentiate into hepatocytes.
In fact, after treatment of CD133+ HSC with the cytokines
FGF4, HGF, bFGF, and IL-6 rotund cells appeared and
typical hepatocyte markers such as a-fetoprotein, albumin,
and MRP2 were induced, as demonstrated in the present
study. This expression pattern and the non-polarized cell
morphology indicates that immature hepatocyte-like cells
developed from CD133+ HSC. Due to their capacity togenerate cells of hepatocyte and endothelial lineage, the
possibility exists that CD133+ HSC can directly support
renewal of injured liver tissue. Taniguchi and colleagues
[12] already demonstrated supportive eﬀects of transplant-
ed EPC in this process. It will be interesting to investigate
the contribution of CD133+ HSC to liver regeneration
in vivo.
The identiﬁcation of CD133+ HSC as not yet recognized
progenitor cells with characteristics of early EPC indicates
that stellate cells fulﬁll functions beyond participation in
liver ﬁbrogenesis. However, HSC are rather exceptional
progenitor cells due to their high retinyl palmitate loads.
Retinoic acid was shown to induce neuronal and astrocyte
markers such as GFAP in CD133+ hematopoietic stem
cells from human umbilical cord blood [21]. Therefore, ret-
inoids may support the neuronal expression pattern of
HSC. In addition, retinoic acid maintains mesenchymal
stem cells in an undiﬀerentiated state [22], this might be
also the case in HSC. In line with this, application of reti-
nol and retinoic acid can counteract stellate cell activation
[23]. Nevertheless, the molecular mechanisms responsible
for the maintenance of HSC in an undiﬀerentiated state
await further evaluation.
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